Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 ...Middle East

MUMBAI, India, Jan. 30, 2024 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Third Quarter (Q3) and Nine Months (9M) ended 31st December 2023. Consolidated...

Read More Details
Finally We wish PressBee provided you with enough information of ( Piramal Pharma Limited Announces Consolidated Results for Q3 and 9M FY2024 )

Also on site :

• Flipster und Aptos Foundation kooperieren, um die Verbreitung von Stablecoin zu fördern und Multichain-Gelegenheiten zu erschließen
• Tesla's driverless robotaxi pilot arrives this weekend — with training wheels
• Brazil's Contradictory Stance on Climate and Fossil Fuels